PL1812058T3 - Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce - Google Patents

Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce

Info

Publication number
PL1812058T3
PL1812058T3 PL05790937T PL05790937T PL1812058T3 PL 1812058 T3 PL1812058 T3 PL 1812058T3 PL 05790937 T PL05790937 T PL 05790937T PL 05790937 T PL05790937 T PL 05790937T PL 1812058 T3 PL1812058 T3 PL 1812058T3
Authority
PL
Poland
Prior art keywords
vaccine
chlamydia trachomatis
diagnostic use
trachomatis antigens
antigens
Prior art date
Application number
PL05790937T
Other languages
English (en)
Inventor
Michael Theisen
Anja Olsen
Robert Leah
Frank Follmann
Klaus Jensen
Peter Andersen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Publication of PL1812058T3 publication Critical patent/PL1812058T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PL05790937T 2004-10-25 2005-10-11 Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce PL1812058T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200401633 2004-10-25
DKPA200501069 2005-07-19
EP05790937A EP1812058B1 (en) 2004-10-25 2005-10-11 Chlamydia trachomatis antigens for vaccine and diagnostic use
PCT/DK2005/000651 WO2006045308A2 (en) 2004-10-25 2005-10-11 Chlamydia trachomatis antigens for vaccine and diagnostic use

Publications (1)

Publication Number Publication Date
PL1812058T3 true PL1812058T3 (pl) 2012-11-30

Family

ID=35686446

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05790937T PL1812058T3 (pl) 2004-10-25 2005-10-11 Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce

Country Status (11)

Country Link
US (1) US8889142B2 (pl)
EP (3) EP1812058B1 (pl)
JP (3) JP5024830B2 (pl)
CA (2) CA2820140A1 (pl)
CY (1) CY1113601T1 (pl)
DK (1) DK1812058T3 (pl)
ES (1) ES2389562T3 (pl)
PL (1) PL1812058T3 (pl)
PT (1) PT1812058E (pl)
SI (1) SI1812058T1 (pl)
WO (1) WO2006045308A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
AU2006259858A1 (en) 2005-05-12 2006-12-28 Novartis Vaccines And Diagnostics S.R.L. Immunogenic compositions for Chlamydia trachomatis
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
EP1970708A1 (de) * 2007-03-07 2008-09-17 Mikrogen Molekularbiologische Entwicklungs-GmbH Biochip und Verfahren zum selektiven Nachweis von Chlamydia trachomatis-Infektionen
JP2010526070A (ja) * 2007-05-01 2010-07-29 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム Ｃｈｌａｍｙｄｉａ感染及び疾患の診断ならびに治療のための薬剤としてのＣｈｌａｍｙｄｉａ抗原
EP2329043B1 (en) * 2008-08-26 2014-12-17 Becton Dickinson and Company Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis cytotoxin gene
US9068007B2 (en) 2008-10-09 2015-06-30 Board Of Regents, The University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
EP2907523B1 (en) * 2009-01-29 2018-03-28 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
BRPI1009892A2 (pt) * 2009-03-24 2016-03-15 Transgène S A método ex-vivo para avaliar a eficácia de um tratamento em um paciente, e, kit para testar se um paciente está respondendo terapeuticamente a um método de tratamento compreendendo administração de uma composição imunogênica
EP2501396B1 (en) * 2009-11-18 2018-04-25 Auburn University Low antigen-dose immunization for maximizing t-helper cell 1 (th1) immunity against disease
EP2544715A2 (en) * 2010-03-09 2013-01-16 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US8735543B2 (en) 2010-05-28 2014-05-27 Spixia Biotechnology Ab Chimeric MOMP antigen
CA2849391A1 (en) * 2010-10-20 2012-04-26 Genocea Biosciences, Inc. Chlamydia antigens and uses thereof
CA2850228A1 (en) * 2011-09-30 2013-04-04 The University Of British Columbia Chlamydia antigen compositions and uses thereof
US9827319B2 (en) 2012-05-29 2017-11-28 The Research Foundation For The State University Of New York Combined therapy and prophylaxis for genital tract infections
ITNA20120046A1 (it) * 2012-08-02 2014-02-03 No Self S R L Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi
PL2976355T3 (pl) * 2013-03-18 2020-07-13 Statens Serum Institut Szczepionki przeciwko Chlamydia sp.
US10835594B2 (en) 2014-01-16 2020-11-17 Mcmaster University Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
NL2022581B1 (en) * 2019-02-14 2020-08-27 Koppert Bv Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production
EP4267181B1 (en) * 2020-12-23 2026-04-15 Daykin Molecular Systems, LLC Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport
AR132053A1 (es) 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia
CN117106078B (zh) * 2023-07-18 2024-09-17 华南农业大学 一种水稻橙叶植原体抗原膜蛋白多克隆抗体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
JP4091112B2 (ja) 1995-06-07 2008-05-28 コノート ラボラトリーズ インコーポレーテッド リポタンパク質の発現
US6136958A (en) 1996-09-30 2000-10-24 Genentech, Inc. Antibodies to vertebrate smoothened proteins
EP0892061A3 (en) * 1997-07-18 1999-02-24 Smithkline Beecham Corporation The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
KR20010032336A (ko) 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
KR100760221B1 (ko) * 1997-11-28 2007-10-30 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6736222B2 (en) 2001-11-05 2004-05-18 Vector Magnetics, Llc Relative drill bit direction measurement
ES2386386T3 (es) * 2001-12-12 2012-08-20 Novartis Vaccines And Diagnostics S.R.L. Inmunización contra Chlamydia trachomatis
EP1597275B1 (en) * 2003-02-24 2010-08-18 Institut Pasteur Use of the Chlamydia pneumoniae CPn0104 polypeptide or antibodies thereto to diagnose Chlamydia infections
WO2005002619A2 (en) * 2003-06-26 2005-01-13 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
US20090028891A1 (en) 2004-11-11 2009-01-29 Queensland University Of Technology Chlamydia Antigens and Uses Thereof

Also Published As

Publication number Publication date
JP5024830B2 (ja) 2012-09-12
US20090304722A1 (en) 2009-12-10
CA2820140A1 (en) 2006-05-04
WO2006045308A8 (en) 2011-08-11
PT1812058E (pt) 2012-09-17
JP2013231050A (ja) 2013-11-14
US8889142B2 (en) 2014-11-18
JP2008520550A (ja) 2008-06-19
CA2585011C (en) 2014-02-18
CY1113601T1 (el) 2016-06-22
EP1812058A2 (en) 2007-08-01
ES2389562T3 (es) 2012-10-29
SI1812058T1 (sl) 2013-02-28
EP2314314A3 (en) 2011-05-11
EP1812058B1 (en) 2012-06-13
EP2269636A3 (en) 2011-04-06
EP2269636A2 (en) 2011-01-05
EP2314314A2 (en) 2011-04-27
JP2012102108A (ja) 2012-05-31
WO2006045308A3 (en) 2006-12-07
DK1812058T3 (da) 2012-09-17
CA2585011A1 (en) 2006-05-04
WO2006045308A2 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
SI1812058T1 (sl) Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo
EP2097534A4 (en) HUMAN ANTIBODIES BINDING TO CD70 AND USES THEREOF
TWI365191B (en) Vaccine
IL183457A0 (en) Il-15 antigen arrays and uses thereof
IL191941A0 (en) Conjugate vaccines
ZA200707339B (en) Human antibodies against rabies and uses thereof
ZA200904657B (en) Human antibodies that bind CD70 and uses thereof
GB0411411D0 (en) Vaccines
IL181733A0 (en) Vaccines comprising plasmodium antigens
IL187479A0 (en) Antigen conjugates and uses thereof
GB0401876D0 (en) New use for cancer antigen
ZA200803664B (en) Chimeric antigens and vaccines
ZA200801874B (en) Antigenic peptides and their use
ZA200709207B (en) Vaccine
ZA200608278B (en) Stabilised TAT Antigen and the use thereof for anit-HIV Vaccination
GB0412407D0 (en) Vaccine
HU0500823D0 (en) Gynaecological and sanitary device
GB0508011D0 (en) Intra-vaginal device
EP1735338A4 (en) ANTHROX ANTIGENS AND METHODS OF USE
SG119341A1 (en) Novel bacterium and vaccine
ZA200805298B (en) Conjugate vaccines
GB0406598D0 (en) Vaccine
GB0522599D0 (en) Adjuvants and antigens
GB0523923D0 (en) Adjuvants and antigens
AP2709A (en) An anti-theileriosis vaccine